ArticleActa pharmacologica Sinica2023

ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming.

Zi-Jian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.